The global cardiovascular–liver– metabolic syndemic: epidemiology, trends and challenges por Walter Suárez Carmona | Oct 8, 2025
Phenome-wide associations of coffee intake in the human phenotype project por Walter Suárez Carmona | Oct 7, 2025
Semaglutide, the first approved GLP-1 receptor agonist for the management of metabolic dysfunction-associated steatohepatitis por Walter Suárez Carmona | Oct 7, 2025
Interaction of inflammation and portal hypertension in cirrhosis progression por Walter Suárez Carmona | Oct 4, 2025
Efectos de los fármacos con acción GLP-1 sobre las comorbilidades o enfermedades relacionadas con obesidad por Walter Suárez Carmona | Oct 4, 2025
